NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
| Drug Number: | 419/07 |
| Drug Name: | dexrazoxane (Cardioxane) 419/07 |
| Drug Manufacturer: | Novartis Pharmaceuticals UK Limited |
| BNF Category: | Malignant disease and immunosuppression |
| Submission type : | Non submission |
| Date Advice Issued: | 12 November 2007 |
| Indication: | for the prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin use in advanced and/or metastatic cancer patients after previous anthracycline containing treatment |
dexrazoxane (Cardioxane) 419/07
There is no statement for this submission
There is currently no other SMC advice for this product